Table I.
β‐Blockers Approved in the United States 7
| Generic Name | Indications |
|---|---|
| Acebutolol | Angina pectoris; ventricular arrhythmias |
| Atenolol | Angina pectoris; hypertension; cardiovascular mortality prophylaxis in post‐MI patients |
| Betaxolol | Hypertension; glaucoma (topical formulation) |
| Bisoprolol | Hypertension |
| Carteolol | Hypertension; glaucoma (topical formulation) |
| Carvedilol | Hypertension; moderate and severe congestive heart failure |
| Esmolol | Supraventricular arrhythmias (IV only) |
| Labetalol | Hypertension; hypertensive emergencies (IV) |
| Metoprolol | Angina pectoris; hypertension; moderate congestive heart failure; cardiovascular mortality prophylaxis in post‐MI patients |
| Nadolol | Hypertension; angina pectoris |
| Nebivolol | Hypertension |
| Oxprenolol | Hypertension |
| Penbutolol | Hypertension |
| Pindolol | Hypertension |
| Propranolol | Angina pectoris; arrhythmias; hypertension; migraine prophylaxis; essential tremor; hypertrophic cardiomyopathy; cardiovascular mortality prophylaxis in post‐MI patients |
| Sotalol | Ventricular and atrial arrhythmias |
| Timolol | Hypertension; cardiovascular mortality prophylaxis in post‐MI patients; glaucoma (topical formulation) |
Abbreviations: IV, intravenous; MI, myocardial infarction.